Our capabilities and research infrastructure:

In-house phase-1 lab

In-house pharmacy

Committed, Board-Certified Clinicians

Dedicated, full-time, experienced research staff

Multiple patient exam rooms

Experienced regulatory and quality assurance staff

Bilingual staff members

Early phase/phase 1 facilities

Backup power generators and emergency water tank

Private monitor rooms for site visits

AI system for appointment management (App Livio)

Our capabilities and research infrastructure:

In-house phase-1 lab

In-house pharmacy

Committed, Board-Certified Clinicians

Dedicated, full-time, experienced research staff

Multiple patient exam rooms

Experienced regulatory and quality assurance staff

Bilingual staff members

Early phase/phase 1 facilities

Backup power generators and emergency water tank

Private monitor rooms for site visits

AI system for appointment management (App Livio)

Medical equipment

In-house phase-1 lab

In-house pharmacy

Committed, Board-Certified Clinicians

Dedicated, full-time, experienced research staff

Multiple patient exam rooms

Experienced regulatory and quality assurance staff

Bilingual staff members

Early phase/phase 1 facilities

Backup power generators and emergency water tank

Private monitor rooms for site visits

AI system for appointment management (App Livio)

We have conducted clinical trials for the following conditions:

MASLD/MASH

Liver cirrhosis and hepatic decompensation

Hepatitis C & B

Influenza

Herpes Zoster

Hematology/Oncology

Chronic Obstructive Pulmonary Disease

Hereditary Angioedema

Asthma

Urticaria

Renal disease

Gynecology

Ulcerative colitis

Chron’s disease

Celiac disease

Zika and Chikungunya

Type 2 Diabetes

Severe dyslipidemia

State of the art facilities

¿Piensa que puede beneficiarse de alguno de nuestros servicios? Contáctenos o coordine una cita.

Programar una cita

Noticias

La encefalopatía hepática podría amenazar tu salud

Cuando ya el hígado no es capaz de filtrar las tóxinas de nuestro cuerpo, puede provocar lo que se denomina […]

FDI ofrece pruebas libres de costos para personas propensas a padecer de la Enfermedad de Hígado graso No-Alcohólica

La Enfermedad del Hígado Graso No-Alcohólica (EHNA) es la nueva epidemia silente en Puerto Rico.

Si tienes hígado graso, podemos ayudarte

El hígado grado es una condición que pudiera desencadenar en cáncer. Sin embargo, la buena noticia es que puedes prevenirlo. […]

FDI Clinical Research
998 Muñoz Rivera Ave.
San Juan, PR 00927

Tel. (787) 722-1248
Fax. (787) 721-6098

Navegación

Noticias

La encefalopatía hepática podría amenazar tu salud

NASH: La Nueva Epidemia del Hígado

Enlaces de Interés

* Si cualificas

Sponsors

Our capabilities and research infrastructure:

Our capabilities and research infrastructure:

Medical equipment

We have conducted clinical trials for the following conditions:

MASLD/MASH

Liver cirrhosis and hepatic decompensation​

Hepatitis C & B​

Influenza​

Herpes Zoster​

Hematology/Oncology​

Chronic Obstructive Pulmonary Disease​

Hereditary Angioedema​

Asthma​

Urticaria

Renal disease​

Gynecology​

Ulcerative colitis​

Chron’s disease​

Celiac disease​

Zika and Chikungunya​

Type 2 Diabetes

Severe dyslipidemia​

State of the art facilities

Noticias

Navegación

Noticias

La encefalopatía hepática podría amenazar tu salud

NASH: La Nueva Epidemia del Hígado

Enlaces de Interés

Liver cirrhosis and hepatic decompensation

Hepatitis C & B

Influenza

Herpes Zoster

Hematology/Oncology

Chronic Obstructive Pulmonary Disease

Hereditary Angioedema

Asthma

Renal disease

Gynecology

Ulcerative colitis

Chron’s disease

Celiac disease

Zika and Chikungunya

Severe dyslipidemia